AbCellera Biologics Inc. (ABCL)
Discovers and develops antibody-based medicines to treat diseases like autoimmune conditions and hot flashes.
$5.23-0.00%Healthcare
StockGlow Score
Leaning Bullish
BearishBullish
1 year ago+23.2%
The outlook
ABCL is trading near the lower end of its 52-week range, with analyst sentiment strongly bullish—the average price target sits roughly double the current price. The stock shows mixed momentum relative to its moving averages, though overall sentiment leans constructive based on analyst coverage.
What’s behind the score
Analyst consensusStrong Buy — 1.1 avg of 8 analysts
Price trendMixed vs its moving averages
52-week range44% of the way from its 52-week low to high
Price targetAvg target +101% vs current price
Analyst price target
~12-month · 8 analysts$10.50average target+101.0% vs now
Now $5.23
Low $7.00High $13.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$1.60B
52-wk high
$8.44
52-wk low
$2.75
50-day avg
$5.97
200-day avg
$4.49
Trailing P/E
—